Targeting SCD1 to Harness the Skin as an Endocrine Organ for Sustainable Weight Loss to Redefine Obesity Care
Time: 11:30 am
day: Pre-Conference Day
Details:
- Targeting SCD1 offers a novel mechanism to increase energy expenditure without elevating heart rate, which provides a well-tolerated and sustainable pathway for weight loss
- This unique approach to lipid metabolism provides the distinct advantage of preferential fat reduction while preserving lean muscle mass, resulting in significant improvements in body composition and metabolic health markers
- The treatment option provides an alternative for patients who are unresponsive to or intolerant of existing therapies, ultimately redefining the standard of care with new pathways for durable weight management
Speakers:
